Remove tag specialty-drugs
article thumbnail

Critical Success Factors for Commercializing Specialty Drugs, Cell and Gene Therapies

Pharmacy Times

Although payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.”

123
123
article thumbnail

Disruptive Tech in Pharma: A Future of Digital Interactions

Viseven

From AI-based drug discovery to running virtual cohorts for clinical trials or doing continuous manufacturing instead of batch manufacturing, from launching a project effectively to doing real-world tickets, there is technology penetration all along the value chain. And then all the technology will be applied to it.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How much is Jublia without insurance?

The Checkup by Singlecare

Jublia is a brand-name prescription drug FDA approved to treat fungal toenail infections (onychomycosis). Its active ingredient, efinaconazole, is a new antifungal drug. In clinical trials, the drug cured the fungal infection in more than half the participants. Jublia is only available as a premium-priced brand-name drug.

article thumbnail

Roche takes on pricey rivals as FDA approves SMA drug

pharmaphorum

Roche is hoping to undercut hugely expensive rivals after the FDA approved its oral spinal muscular atrophy (SMA) drug Evrysdi (risdiplam). While this is not cheap by anybody’s reckoning, Roche hopes that the less intimidating price tag, plus the patient-friendly oral administration method will give it a competitive edge.

FDA 59
article thumbnail

Osteopathic Medicine and Surviving Your Second Year of Medical School with Dr. Bryce Brohol ?

The Physician Pharmacist

[link] The podcast is structured around several goals, including an overview of the medical school application process, a discussion of osteopathic vs. allopathic medical education, and insights into medical research and specialty choices. Just for example, I loved oncology class. Speaker 2 So it's it's kind of a little bit of a given take.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean probably the only real exception is in specialty pharma in terms of, underlying cost actually having gone up. Even there, that’s impacted by some distortions around pbms and how hospitals radically markup those drugs, but that’s probably the one exception. Don (PMN): The specialty pharmacy.